LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Moll, C.; Gessler, U.; Bartsch, S.; El-Sayeh, H.G.; Fenton, M.; Adams, C.E. (2003)
Languages: English
Types: Article
Subjects: RC0321
The 5000 randomised controlled trials (RCTs) in the Cochrane Schizophrenia Group's database affords an opportunity to research for variables related to the differences between nations of their output of schizophrenia trials.\ud \ud Ecological study – investigating the relationship between four economic/demographic variables and number of schizophrenia RCTs per country. The variable with closest correlation was used to predict the expected number of studies.\ud \ud GDP closely correlated with schizophrenia trial output, with 76% of the total variation about the Y explained by the regression line (r = 0.87, 95% CI 0.79 to 0.92, r2 = 0.76). Many countries have a strong tradition of schizophrenia trials, exceeding their predicted output. All nations with no identified trial output had GDPs that predicted zero trial activity. Several nations with relatively small GDPs are, nevertheless, highly productive of trials. Some wealthy countries seem either not to have produced the expected number of randomised trials or not to have disseminated them to the English-speaking world.\ud \ud This hypothesis-generating study could not investigate causal relationships, but suggests, that for those seeking all relevant studies, expending effort searching the scientific literature of Germany, Italy, France, Brazil and Japan may be a good investment.\ud
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Thornley B, Adams CE: Content and quality of 2000 controlled trials in schizophrenia over 50 years. BMJ 1998, 317:1181-1184.
    • 2. Adams CE, Duggan L, Wahlbeck K, White P: The Cochrane Schizophrenia Group. Schizophrenia Research 1998, 33:185-186.
    • 3. Sims L: MeerKat Version 1.1 2001 [http://www.update-software.com]. Oxford: Update Software
    • 4. United Nations Publications, InfoNation [http://www.un.org/ Pubs/CyberSchoolBus/infonation/e_infonation.htm]. Accessed 16/09/ 2003
    • 5. WorldRover.com: WorldRover Vital Statistics [http:// www.worldrover.com/vitalmain.htm]. Accessed 16/09/2003
    • 6. StatsDirect Cambridge, England: CamCode 2001 [http://www.cam code.com/].
    • 7. Furukawa TA, Inada T, Adams CE, McGuire H, Inagaki A, Nozaki S: Are the Cochrane group registers comprehensive? A case study of Japanese psychiatry trials. BMC Psychiatry 2002, 2:6.
    • 8. Inada T, Inagaki A, Otsuki N, Yoshio T: Psychotropic drugs: Evidence of the 20th century in Japan Tokyo, Japan: Seiwa Shoten; 2000.
    • 9. Armitage P, Berry G: Statistical methods in medical research Oxford, Boston: Blackwell Scientific Publications; 1994.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article